Page last updated: 2024-08-23

buserelin and Leiomyomatosis

buserelin has been researched along with Leiomyomatosis in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (80.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aliaga, R; Armero, C; Cano, A; Puértolas, C; Tortajada, M	1
Chou, CY; Lee, WY; Tzeng, CC	1
Chang, SY; ChangChien, CC; Hsu, TY; Lin, JW; Tseng, CW	1
Katabuchi, H; Kitano, Y; Matsuno, Y; Okamura, H; Shimamura, T; Takahashi, M; Yamashita, Y	1
Ishii, M; Kono, T; Taniguchi, S	1

Reviews

1 review(s) available for buserelin and Leiomyomatosis

Article	Year
Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist. Gynecologic oncology, 1994, Volume: 52, Issue:1 Topics: Adult; Buserelin; Estrogens; Fallopian Tubes; Female; Follow-Up Studies; Humans; Hysterectomy; Leiomyomatosis; Leiomyosarcoma; Lymph Node Excision; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Ovariectomy; Pelvis; Uterine Hemorrhage; Uterine Neoplasms	1994

Article

Year

Uterine leiomyosarcomas coexistent with cellular and atypical leiomyomata in a young woman during the treatment with luteinizing hormone-releasing hormone agonist.

Gynecologic oncology, 1994, Volume: 52, Issue:1

Topics: Adult; Buserelin; Estrogens; Fallopian Tubes; Female; Follow-Up Studies; Humans; Hysterectomy; Leiomyomatosis; Leiomyosarcoma; Lymph Node Excision; Neoplasms, Hormone-Dependent; Neoplasms, Second Primary; Ovariectomy; Pelvis; Uterine Hemorrhage; Uterine Neoplasms

1994

Trials

1 trial(s) available for buserelin and Leiomyomatosis

Article	Year
Influence of the ovary on parameters of LH secretion during the recovery from buserelin-induced desensitization. European journal of obstetrics, gynecology, and reproductive biology, 1994, Jun-30, Volume: 55, Issue:3 Topics: Administration, Intranasal; Adult; Buserelin; Female; Humans; Hysterectomy; Leiomyomatosis; Luteinizing Hormone; Middle Aged; Ovariectomy; Ovary; Premenopause; Radioimmunoassay; Remission Induction; Uterine Neoplasms	1994

Article

Year

Influence of the ovary on parameters of LH secretion during the recovery from buserelin-induced desensitization.

European journal of obstetrics, gynecology, and reproductive biology, 1994, Jun-30, Volume: 55, Issue:3

Topics: Administration, Intranasal; Adult; Buserelin; Female; Humans; Hysterectomy; Leiomyomatosis; Luteinizing Hormone; Middle Aged; Ovariectomy; Ovary; Premenopause; Radioimmunoassay; Remission Induction; Uterine Neoplasms

1994

Other Studies

3 other study(ies) available for buserelin and Leiomyomatosis

Article	Year
Leiomyomatosis peritonealis disseminata (LPD) with acute ascites induced by gonadotropin-releasing hormone (GnRH) agonist: a case report. Changgeng yi xue za zhi, 1996, Volume: 19, Issue:4 Topics: Acute Disease; Adult; Ascites; Buserelin; Female; Humans; Leiomyomatosis; Peritoneal Neoplasms	1996
Predicting the effect of gonadotropin-releasing hormone (GnRH) analogue treatment on uterine leiomyomas based on MR imaging. Acta radiologica (Stockholm, Sweden : 1987), 1999, Volume: 40, Issue:6 Topics: Administration, Inhalation; Adult; Antineoplastic Agents, Hormonal; Buserelin; Female; Humans; Leiomyomatosis; Magnetic Resonance Imaging; Middle Aged; Predictive Value of Tests; Treatment Outcome; Uterine Neoplasms	1999
Intranasal buserelin acetate-induced pigmented roseola-like eruption. The British journal of dermatology, 2000, Volume: 143, Issue:3 Topics: Antineoplastic Agents, Hormonal; Buserelin; Drug Eruptions; Female; Humans; Leiomyomatosis; Middle Aged; Patch Tests; Uterine Neoplasms	2000